These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32482674)
1. Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model. Arias LS; Butcher MC; Short B; McKloud E; Delaney C; Kean R; Monteiro DR; Williams C; Ramage G; Brown JL Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482674 [No Abstract] [Full Text] [Related]
2. Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model. Garcia-Bustos V; Ruiz-Saurí A; Ruiz-Gaitán A; Sigona-Giangreco IA; Cabañero-Navalon MD; Sabalza-Baztán O; Salavert-Lletí M; Tormo MÁ; Pemán J Microbiol Spectr; 2021 Sep; 9(1):e0001321. PubMed ID: 34106570 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380 [TBL] [Abstract][Full Text] [Related]
4. Virulence of Hernando-Ortiz A; Mateo E; Perez-Rodriguez A; de Groot PWJ; Quindós G; Eraso E Virulence; 2021 Dec; 12(1):1063-1075. PubMed ID: 33843456 [No Abstract] [Full Text] [Related]
5. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris. Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569 [TBL] [Abstract][Full Text] [Related]
6. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections. Mannala GK; Rupp M; Walter N; Scholz KJ; Simon M; Riool M; Alt V J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929 [TBL] [Abstract][Full Text] [Related]
7. The Galleria mellonella infection model as a system to investigate the virulence of Candida auris strains. Romera D; Aguilera-Correa JJ; García-Coca M; Mahillo-Fernández I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J Pathog Dis; 2020 Nov; 78(9):. PubMed ID: 33098293 [TBL] [Abstract][Full Text] [Related]
8. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375 [No Abstract] [Full Text] [Related]
9. The Use of Galleria mellonella Larvae to Study the Pathogenicity and Clonal Lineage-Specific Behaviors of the Emerging Fungal Pathogen Candida auris. Borman AM Methods Mol Biol; 2022; 2517():287-298. PubMed ID: 35674963 [TBL] [Abstract][Full Text] [Related]
11. Small molecules restore azole activity against drug-tolerant and drug-resistant Alabi PE; Gautier C; Murphy TP; Gu X; Lepas M; Aimanianda V; Sello JK; Ene IV mBio; 2023 Aug; 14(4):e0047923. PubMed ID: 37326546 [TBL] [Abstract][Full Text] [Related]
12. Host-pathogen interactions upon Garcia-Bustos V; Pemán J; Ruiz-Gaitán A; Cabañero-Navalon MD; Cabanilles-Boronat A; Fernández-Calduch M; Marcilla-Barreda L; Sigona-Giangreco IA; Salavert M; Tormo-Mas MÁ; Ruiz-Saurí A Emerg Microbes Infect; 2022 Dec; 11(1):136-146. PubMed ID: 34890523 [No Abstract] [Full Text] [Related]
13. Galleria mellonella for systemic assessment of anti-Candida auris using amphotericin B loaded in nanoemulsion. Marena GD; Ramos MADS; Lima LC; Chorilli M; Bauab TM Sci Total Environ; 2022 Feb; 807(Pt 3):151023. PubMed ID: 34662607 [TBL] [Abstract][Full Text] [Related]
14. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. Borman AM; Szekely A; Johnson EM mSphere; 2016; 1(4):. PubMed ID: 27547827 [TBL] [Abstract][Full Text] [Related]
15. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris. Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262 [No Abstract] [Full Text] [Related]
16. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. Chow NA; Muñoz JF; Gade L; Berkow EL; Li X; Welsh RM; Forsberg K; Lockhart SR; Adam R; Alanio A; Alastruey-Izquierdo A; Althawadi S; Araúz AB; Ben-Ami R; Bharat A; Calvo B; Desnos-Ollivier M; Escandón P; Gardam D; Gunturu R; Heath CH; Kurzai O; Martin R; Litvintseva AP; Cuomo CA mBio; 2020 Apr; 11(2):. PubMed ID: 32345637 [No Abstract] [Full Text] [Related]
17. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Mesa-Arango AC; Forastiero A; Bernal-Martínez L; Cuenca-Estrella M; Mellado E; Zaragoza O Med Mycol; 2013 Jul; 51(5):461-72. PubMed ID: 23170962 [TBL] [Abstract][Full Text] [Related]
18. Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Marena GD; Ruiz-Gaitán A; Garcia-Bustos V; Tormo-Mas MÁ; Pérez-Royo JM; López A; Bernarbe P; Pérez Ruiz MD; Zaragoza Macian L; Vicente Saez C; Avalos Mansilla A; Gómez EV; Carvalho GC; Bauab TM; Chorilli M; Pemán J Microorganisms; 2023 Jun; 11(7):. PubMed ID: 37512799 [No Abstract] [Full Text] [Related]
20. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]